271 related articles for article (PubMed ID: 32324179)
1. Bempedoic acid (Nexletol) for lowering LDL-cholesterol.
Med Lett Drugs Ther; 2020 Apr; 62(1595):53-55. PubMed ID: 32324179
[No Abstract] [Full Text] [Related]
2. Lipid-lowering drugs.
Med Lett Drugs Ther; 2019 Feb; 61(1565):17-24. PubMed ID: 30845106
[No Abstract] [Full Text] [Related]
3. Lipid-lowering drugs.
Med Lett Drugs Ther; 2022 Sep; 64(1659):145-152. PubMed ID: 36094548
[No Abstract] [Full Text] [Related]
4. Comparison table: Some lipid-lowering drugs.
Med Lett Drugs Ther; 2022 Sep; 64(1659):e152-e158. PubMed ID: 36094549
[No Abstract] [Full Text] [Related]
5. Comparison table: Some lipid-lowering drugs.
Med Lett Drugs Ther; 2019 Feb; 61(1565):e24-e30. PubMed ID: 30845107
[No Abstract] [Full Text] [Related]
6. A new indication for bempedoic acid (Nexletol).
Med Lett Drugs Ther; 2024 May; 66(1702):75-77. PubMed ID: 38696311
[No Abstract] [Full Text] [Related]
7. Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial.
Lalwani ND; Hanselman JC; MacDougall DE; Sterling LR; Cramer CT
J Clin Lipidol; 2019; 13(4):568-579. PubMed ID: 31202641
[TBL] [Abstract][Full Text] [Related]
8. Expanded table: statins.
Med Lett Drugs Ther; 2019 Sep; 61(1581):e152. PubMed ID: 31599870
[No Abstract] [Full Text] [Related]
9. Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase.
Bilen O; Ballantyne CM
Curr Atheroscler Rep; 2016 Oct; 18(10):61. PubMed ID: 27663902
[TBL] [Abstract][Full Text] [Related]
10. In brief: Cardiovascular outcomes with bempedoic acid (Nexletol).
Med Lett Drugs Ther; 2023 Apr; 65(1674):62-63. PubMed ID: 37039614
[No Abstract] [Full Text] [Related]
11. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
Ray KK; Bays HE; Catapano AL; Lalwani ND; Bloedon LT; Sterling LR; Robinson PL; Ballantyne CM;
N Engl J Med; 2019 Mar; 380(11):1022-1032. PubMed ID: 30865796
[TBL] [Abstract][Full Text] [Related]
12. Inclisiran (Leqvio) for LDL-cholesterol lowering.
Med Lett Drugs Ther; 2022 Mar; 64(1646):43-45. PubMed ID: 35294427
[No Abstract] [Full Text] [Related]
13. Evinacumab (Evkeeza) for homozygous familial hypercholesterolemia.
Med Lett Drugs Ther; 2021 May; 63(1623):66-67. PubMed ID: 33976097
[No Abstract] [Full Text] [Related]
14. Bempedoic acid, an inhibitor of ATP citrate lyase for the treatment of hypercholesterolemia: early indications and potential.
Brandts J; Ray KK
Expert Opin Investig Drugs; 2020 Aug; 29(8):763-770. PubMed ID: 32564642
[TBL] [Abstract][Full Text] [Related]
15. Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside.
Agarwala A; Quispe R; Goldberg AC; Michos ED
Drug Des Devel Ther; 2021; 15():1955-1963. PubMed ID: 34007155
[TBL] [Abstract][Full Text] [Related]
16. Role of Bempedoic Acid in Dyslipidemia Management.
Kelly MS; Sulaica EM; Beavers CJ
J Cardiovasc Pharmacol; 2020 Oct; 76(4):376-388. PubMed ID: 32732494
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis.
Cicero AFG; Fogacci F; Hernandez AV; Banach M;
PLoS Med; 2020 Jul; 17(7):e1003121. PubMed ID: 32673317
[TBL] [Abstract][Full Text] [Related]
18. Bempedoic acid: effect of ATP-citrate lyase inhibition on low-density lipoprotein cholesterol and other lipids.
Paton DM
Drugs Today (Barc); 2020 Sep; 56(9):573-582. PubMed ID: 33025951
[TBL] [Abstract][Full Text] [Related]
19. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial.
Goldberg AC; Leiter LA; Stroes ESG; Baum SJ; Hanselman JC; Bloedon LT; Lalwani ND; Patel PM; Zhao X; Duell PB
JAMA; 2019 Nov; 322(18):1780-1788. PubMed ID: 31714986
[TBL] [Abstract][Full Text] [Related]
20. A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia.
Niman S; Rana K; Reid J; Sheikh-Ali M; Lewis T; Choksi RR; Goldfaden RF
Am J Cardiovasc Drugs; 2020 Dec; 20(6):535-548. PubMed ID: 32166726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
